Glycobiology Advance Access originally published online on February 20, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Glycobiology, 2003, Vol. 13, No. 6 487-495
© 2003 Oxford University Press
Evidence for a sialic acid salvaging pathway in lepidopteran insect cells
2 Department of Molecular Biology, University of Wyoming, Laramie, WY 82071, USA
3 Protein Glycosylation, Gesellschaft Fur Biotechnologische Forschung mbH, Braunschweig, Germany
Received on December 26, 2002; revised on January 27, 2003; accepted on February 5, 2003
We previously described a transgenic insect cell line, Sfß4GalT/ST6, that expresses mammalian ß-1,4-galactosyltransferase and 
2,6-sialyltransferase genes and produces glycoproteins with terminally sialylated N-glycans. The ability of these cells to produce sialylated N-glycans was surprising because insect cells contain only small amounts of sialic acid and no detectable CMP–sialic acid. Thus, it was of interest to investigate potential sources of sialic acids for sialoglycoprotein synthesis by these cells. We found that Sfß4GalT/ST6 cells can produce sialylated N-glycans when cultured in the presence but not in the absence of fetal bovine serum. The serum component(s) supporting N-glycan sialylation by Sfß4GalT/ST6 cells is relatively large—it was not removed by dialysis in a 50,000-molecular-weight cutoff membrane. Serum-free media supplemented with purified fetuin but not asialofetuin supported N-glycan sialylation by Sfß4GalT/ST6 cells. The terminally sialylated N-glycans isolated from fetuin also supported glycoprotein sialylation by Sfß4GalT/ST6 cells. Finally, serum-free medium supplemented with N-acetylneuraminic acid or N-acetylmannosamine supported glycoprotein sialylation by Sfß4GalT/ST6 cells but to a much lower degree than serum or fetuin. These results provide the first evidence of a sialic acid salvaging pathway in insect cells, which begins to explain how Sfß4GalT/ST6 and other transgenic insect cell lines can sialylate recombinant glycoproteins in the absence of a more obvious source of CMP–sialic acid.
1 To whom correspondence should be addressed; e-mail: dljarvis{at}uwyo.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. N. Prince, E. J. Foulstone, O. J. Zaccheo, C. Williams, and A. B. Hassan Functional evaluation of novel soluble insulin-like growth factor (IGF)-II-specific ligand traps based on modified domain 11 of the human IGF2 receptor Mol. Cancer Ther., February 1, 2007; 6(2): 607 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Legardinier, D. Klett, J.-C. Poirier, Y. Combarnous, and C. Cahoreau Mammalian-like nonsialyl complex-type N-glycosylation of equine gonadotropins in MimicTM insect cells Glycobiology, August 1, 2005; 15(8): 776 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Legardinier, M. Duonor-Cerutti, G. Devauchelle, Y. Combarnous, and C. Cahoreau Biological activities of recombinant equine luteinizing hormone/chorionic gonadotropin (eLH/CG) expressed in Sf9 and Mimic insect cell lines J. Mol. Endocrinol., February 1, 2005; 34(1): 47 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Vadaie and D. L. Jarvis Molecular Cloning and Functional Characterization of a Lepidopteran Insect {beta}4-N-Acetylgalactosaminyltransferase with Broad Substrate Specificity, a Functional Role in Glycoprotein Biosynthesis, and a Potential Functional Role in Glycolipid Biosynthesis J. Biol. Chem., August 6, 2004; 279(32): 33501 - 33518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Aumiller, J. R. Hollister, and D. L. Jarvis A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins Glycobiology, June 1, 2003; 13(6): 497 - 507. [Abstract] [Full Text] [PDF]
|
|